BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26587751)

  • 1. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
    Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
    Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
    Fehm TN; Meier-Stiegen F; Driemel C; Jäger B; Reinhardt F; Naskou J; Franken A; Neubauer H; Neves RPL; van Dalum G; Ruckhäberle E; Niederacher D; Rox JM; Fischer JC; Stoecklein NH
    Cytometry A; 2018 Dec; 93(12):1213-1219. PubMed ID: 30551262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
    Fischer JC; Niederacher D; Topp SA; Honisch E; Schumacher S; Schmitz N; Zacarias Föhrding L; Vay C; Hoffmann I; Kasprowicz NS; Hepp PG; Mohrmann S; Nitz U; Stresemann A; Krahn T; Henze T; Griebsch E; Raba K; Rox JM; Wenzel F; Sproll C; Janni W; Fehm T; Klein CA; Knoefel WT; Stoecklein NH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16580-5. PubMed ID: 24065821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
    Andree KC; Mentink A; Zeune LL; Terstappen LWMM; Stoecklein NH; Neves RP; Driemel C; Lampignano R; Yang L; Neubauer H; Fehm T; Fischer JC; Rossi E; Manicone M; Basso U; Marson P; Zamarchi R; Loriot Y; Lapierre V; Faugeroux V; Oulhen M; Farace F; Fowler G; Sousa Fontes M; Ebbs B; Lambros M; Crespo M; Flohr P; de Bono JS
    Int J Cancer; 2018 Nov; 143(10):2584-2591. PubMed ID: 30006930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
    Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
    Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
    Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
    Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells.
    Rieckmann LM; Spohn M; Ruff L; Agorku D; Becker L; Borchers A; Krause J; O'Reilly R; Hille J; Velthaus-Rusik JL; Beumer N; Günther A; Willnow L; Imbusch CD; Iglauer P; Simon R; Franzenburg S; Winter H; Thomas M; Bokemeyer C; Gagliani N; Krebs CF; Sprick M; Hardt O; Riethdorf S; Trumpp A; Stoecklein NH; Peine S; Rosenstiel P; Pantel K; Loges S; Janning M
    Mol Cancer; 2024 May; 23(1):93. PubMed ID: 38720314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
    Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
    Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
    Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
    Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products.
    Guglielmi R; Lai Z; Raba K; van Dalum G; Wu J; Behrens B; Bhagat AAS; Knoefel WT; Neves RPL; Stoecklein NH
    Sci Rep; 2020 Nov; 10(1):20312. PubMed ID: 33219265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
    Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY; Chang YC
    Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells.
    Mishra A; Dubash TD; Edd JF; Jewett MK; Garre SG; Karabacak NM; Rabe DC; Mutlu BR; Walsh JR; Kapur R; Stott SL; Maheswaran S; Haber DA; Toner M
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16839-16847. PubMed ID: 32641515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cell isolation and diagnostics: toward routine clinical use.
    van de Stolpe A; Pantel K; Sleijfer S; Terstappen LW; den Toonder JM
    Cancer Res; 2011 Sep; 71(18):5955-60. PubMed ID: 21896640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells: liquid biopsy of cancer.
    Alix-Panabières C; Pantel K
    Clin Chem; 2013 Jan; 59(1):110-8. PubMed ID: 23014601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.